1. You are here:  
  2. Home
  3. Policies and Documents
  4. Medicines Optimisation documents
  5. Position Statements

Position Statements

Below you will find Medicines Optimisation position statements published by Frimley ICB. These have been written mindful of our priority to purchase those medicines and treatments that are proven to work well, can demonstrate an improvement in people's health and offer good value for money.  ICBs understand that there will be times when a patient may benefit from a treatment not usually given by the NHS. Visit the Individual Funding Requests website for more information.

004 MOG Position Statement- Use of benzodiazepines and anxiolytics/hypnotics for jet lag, flight anxiety, anxiety related to dental procedures or claustrophobia related to diagnostic scanners
004 MOG Position Statement- Use of benzodiazepines and anxiolytics/hypnotics for jet lag, flight anxiety, anxiety related to dental procedures or claustrophobia related to diagnostic scanners
022 MOG Position Statement- Safety needles and safety lancets
022 MOG Position Statement- Safety needles and safety lancets
005 MOG Position Statement- Prescribing guidance for patients travelling abroad
005 MOG Position Statement- Prescribing guidance for patients travelling abroad
001 MOG Position Statement - Adrenaline autoinjector supply
001 MOG Position Statement - Adrenaline autoinjector supply
019 MOG Position Statement- Continuous Glucose Monitoring (CGM) and pregnancy
019 MOG Position Statement- Continuous Glucose Monitoring (CGM) and pregnancy
008 MOG Postion Statement- Salbutamol inhalers in schools
008 MOG Postion Statement- Salbutamol inhalers in schools
018 MOG Position Statement- Generics and biosimilar prescribing
018 MOG Position Statement- Generics and biosimilar prescribing
006 MOG Position Statement- Prescribing gluten free foods in NHS Frimley
006 MOG Position Statement- Prescribing gluten free foods in NHS Frimley
017 MOG Position Statement- Methotrexate 10mg tablets
017 MOG Position Statement- Methotrexate 10mg tablets
016 MOG Position Statement- Treatment of dental pain and infections in primary care
016 MOG Position Statement- Treatment of dental pain and infections in primary care
002 MOG Position Statement - Items which should not routinely be prescribed in primary care
002 MOG Position Statement - Items which should not routinely be prescribed in primary care
003 MOG Position Statement - Conditions for which over the counter (OTC) items should not routinely be prescribed in primary care
003 MOG Position Statement - Conditions for which over the counter (OTC) items should not routinely be prescribed in primary care
015 MOG Position statement Continuous Glucose Monitoring (CGM)
015 MOG Position statement Continuous Glucose Monitoring (CGM)
014 MOG Position Statement IQoro
014 MOG Position Statement IQoro
013 MOG Position Statement - ActiPatch
013 MOG Position Statement - ActiPatch
012 MOG Position Statement- Recommendations for the usual duration of repeat prescriptions
012 MOG Position Statement- Recommendations for the usual duration of repeat prescriptions
Prescribing requests for ADHD patients seen by private consultants
Prescribing requests for ADHD patients seen by private consultants
011 MOG Position Statement- prescribing low protein products for phenylketonuria (PKU)
011 MOG Position Statement- prescribing low protein products for phenylketonuria (PKU)
010 MOG Position Statement- primary care prescribing guidelines for oral paracetamol in adults at risk of hepatotoxicity (including low body weight)
010 MOG Position Statement- primary care prescribing guidelines for oral paracetamol in adults at risk of hepatotoxicity (including low body weight)
Primary care prescribing for people who access gender identity services
Primary care prescribing for people who access gender identity services

Quick Links

Our Partners

Search